
Lurasidone Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 20 mg, 40 mg, 60 mg, 80 mg, 120 mg
Reference Brands: Latuda® (US)
Category: Antipsychotropic Drugs
Lurasidone Tablets is available in Oral Tablets and strengths such as 20 mg, 40 mg, 60 mg, 80 mg, 120 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lurasidone Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lurasidone Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Lurasidone tablets are FDA-approved in the United States for the treatment of schizophrenia and bipolar depression (bipolar I disorder) in adults and adolescents. In the European Union, Lurasidone is authorized under the brand name Latuda for schizophrenia in adults and adolescents aged 13 years and older, via centralized EMA procedures. Regulatory requirements include GMP-compliant manufacturing, clinical trial data demonstrating efficacy and safety, and documentation addressing metabolic effects, akathisia, and suicidality risks. U.S. submissions must comply with boxed warning requirements, while EMA approval requires Risk Management Plans (RMPs) and ongoing pharmacovigilance. To explore dossier-ready Lurasidone tablets and sourcing options, visit Pharmatradz.com — your trusted B2B pharma partner.
Frequently Asked Questions
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View DetailsZuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View DetailsZuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View DetailsZuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers